Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients
Nicolini, Franck Emmanuel, Dulucq, Stéphanie, Boureau, Lisa, Cony-Makhoul, Pascale, Charbonnier, Aude, Escoffre-Barbe, Martine, Rigal-Huguet, Françoise, Coiteux, Valérie, Varet, Bruno, Dubruille, Viviane, Lenain, Pascal, Rousselot, Philippe, Rea, Delphine, Guerci-Bresler, Agnès, Legros, Laurence, Liu, Jixing, Gardembas, Martine, Ianotto, Jean-Christophe, Turlure, Pascal, Johnson-Ansah, Hyacinthe, Martiniuc, Juliana, Jardel, Henry, Joly, Bertrand, Zunic, Patricia, Henni, Tawfiq, Villemagne, Bruno, Berger, Marc G, Cayssials, Emilie, Guilhot, François, Larosa, Fabrice, Guilhot, Joëlle, Etienne, Gabriel, Mahon, François-Xavier
Published in Clinical cancer research (15.11.2019)
Published in Clinical cancer research (15.11.2019)
Get full text
Journal Article
Kinetics of early and late molecular recurrences after first-line imatinib cessation in chronic myeloid leukemia: updated results from the STIM2 trial
Dulucq, Stéphanie, Nicolini, Franck E, Rea, Delphine, Cony-Makhoul, Pascale, Charbonnier, Aude, Escoffre-Barbe, Martine, Coiteux, Valérie, Lenain, Pascal, Rigal-Huguet, Françoise, Liu, Jixing, Guerci-Bresler, Agnès, Legros, Laurence, Ianotto, Jean-Christophe, Gardembas, Martine, Turlure, Pascal, Dubruille, Viviane, Rousselot, Philippe, Martiniuc, Juliana, Jardel, Henry, Johnson-Ansah, Hyacinthe, Joly, Bertrand, Henni, Tawfiq, Cayssials, Emilie, Zunic, Patricia, Berger, Marc G, Villemagne, Bruno, Robbesyn, Fanny, Morisset, Stephane, Mahon, François-Xavier, Etienne, Gabriel
Published in Haematologica (Roma) (01.12.2022)
Published in Haematologica (Roma) (01.12.2022)
Get full text
Journal Article